Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19

被引:11
|
作者
Morad, Razieh [1 ]
Akbari, Mahmood [2 ]
Maaza, Malik [1 ,2 ]
机构
[1] Univ South Africa UNISA, Coll Grad Studies, UNESCO UNISA iTLABS Africa Chair Nanosci & Nanotec, Pretoria, South Africa
[2] Natl Res Fdn, Mat Res Div, iThemba LABS, Nanosci African Network NANOAFNET, ZA-7129 Somerset West, South Africa
关键词
D O I
10.1557/s43580-023-00590-6
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study focuses on computational studies of chemical reactivity descriptors of some proposed drugs for COVID-19. Density functional theory calculations were used to optimize the structure and investigate the frontier orbitals and the chemical reactivity descriptors of these drugs. The frontier orbitals, which include both the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), play an essential role in molecular interactions and chemical reactivity of molecule. Polarizability, which determines the response of the susceptibility of a molecule to an approaching charge, is higher in the more complex drugs such as Hydroxychloroquine, Remdesivir, and Ivermectin compare to the smaller drugs. The HOMO and LUMO orbital energies were calculated to obtain the energy gap of the studied drugs, which is in the following order: Favipiravir < Hydroxychloroquine, Remdesivir < Ivermectin < Artesunate < Artemether < Artemisinin. Generally, molecules with a larger energy gap have lower chemical reactivity and higher kinetic stability.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 50 条
  • [1] Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19
    Razieh Morad
    Mahmood Akbari
    Malik Maaza
    MRS Advances, 2023, 8 : 656 - 660
  • [2] Perspective: repurposed drugs for COVID-19
    Na-Bangchang, Kesara
    Porasuphatana, Supatra
    Karbwang, Juntra
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (05) : 1378 - 1391
  • [3] Study Aims to Identify Drugs That Could Be Repurposed for COVID-19
    Rubin, Rita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (20): : 2019 - 2019
  • [4] Repurposed GI Drugs in the Treatment of COVID-19
    Enrik John T. Aguila
    Ian Homer Y. Cua
    Digestive Diseases and Sciences, 2020, 65 : 2452 - 2453
  • [5] REPURPOSED DRUGS FOR TREATMENT AGAINST COVID-19
    Dwivedi, Jayati
    Singh, Vishal K.
    Raj, Rupa
    Singh, Ramendra K.
    EVERYMANS SCIENCE, 2021, 56 (3-4): : 95 - 100
  • [6] Repurposed GI Drugs in the Treatment of COVID-19
    Aguila, Enrik John T.
    Cua, Ian Homer Y.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2452 - 2453
  • [7] Repurposed Drugs Failed to Prevent Severe COVID-19
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (12): : 1171 - 1171
  • [8] An Overview of Repurposed Drugs for Potential COVID-19 Treatment
    Govender, Kamini
    Chuturgoon, Anil
    ANTIBIOTICS-BASEL, 2022, 11 (12):
  • [9] Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
    Martinez, Miguel Angel
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Impact of repurposed drugs on the symptomatic COVID-19 patients
    Hussain, Iqbal
    Hussain, Afzal
    Alajmi, Mohamed F.
    Rehman, Md Tabish
    Amir, Samira
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (01) : 24 - 38